Assessing optimism and pessimism about genomic medicine

Development of a genomic orientation scale

Caroline Horrow, Joel E. Pacyna, Erica J. Sutton, Beau P. Sperry, Carmen Radecki Breitkopf, Richard R Sharp

Research output: Contribution to journalArticle

Abstract

Efforts to characterize stakeholder attitudes about the implementation of genomic medicine would benefit from a validated instrument for measuring public views of the potential benefits and harms of genomic technologies, which would facilitate comparison across populations and clinical settings. We sought to develop a scale to evaluate attitudes about the future of genomic medicine. We developed a 21-item scale that examined the likelihood of various outcomes of genomic medicine. The scale was administered to participants in a genomic sequencing study. Exploratory factor analysis was conducted and bivariate correlations were calculated. The genomic orientation (GO) scale was completed by 2895 participants. A two-factor structure was identified, corresponding to an optimism subscale (16 items, α = 0.89) and a pessimism subscale (5 items, α = 0.63). Genomic optimism was positively associated with a perceived value of genetic test results, higher health literacy, and decreased decisional conflict about participation in a genomic research study. Genomic pessimism was associated with concerns about genetic testing, lower health literacy, and increased decisional conflict about the decision to participate in the study. The GO scale is a promising tool for measuring both positive and negative views regarding the future of genomic medicine and deserves further validation.

Original languageEnglish (US)
JournalClinical Genetics
DOIs
StatePublished - Jan 1 2019

Fingerprint

Medicine
Health Literacy
Genetic Testing
Statistical Factor Analysis
Technology
Optimism
Pessimism
Research
Population
Conflict (Psychology)

Keywords

  • attitudes
  • factor analysis
  • genetic testing
  • genomics
  • optimism
  • pessimism
  • statistical

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Assessing optimism and pessimism about genomic medicine : Development of a genomic orientation scale. / Horrow, Caroline; Pacyna, Joel E.; Sutton, Erica J.; Sperry, Beau P.; Radecki Breitkopf, Carmen; Sharp, Richard R.

In: Clinical Genetics, 01.01.2019.

Research output: Contribution to journalArticle

@article{d5c916d0874343b29c5888fa898b4f98,
title = "Assessing optimism and pessimism about genomic medicine: Development of a genomic orientation scale",
abstract = "Efforts to characterize stakeholder attitudes about the implementation of genomic medicine would benefit from a validated instrument for measuring public views of the potential benefits and harms of genomic technologies, which would facilitate comparison across populations and clinical settings. We sought to develop a scale to evaluate attitudes about the future of genomic medicine. We developed a 21-item scale that examined the likelihood of various outcomes of genomic medicine. The scale was administered to participants in a genomic sequencing study. Exploratory factor analysis was conducted and bivariate correlations were calculated. The genomic orientation (GO) scale was completed by 2895 participants. A two-factor structure was identified, corresponding to an optimism subscale (16 items, α = 0.89) and a pessimism subscale (5 items, α = 0.63). Genomic optimism was positively associated with a perceived value of genetic test results, higher health literacy, and decreased decisional conflict about participation in a genomic research study. Genomic pessimism was associated with concerns about genetic testing, lower health literacy, and increased decisional conflict about the decision to participate in the study. The GO scale is a promising tool for measuring both positive and negative views regarding the future of genomic medicine and deserves further validation.",
keywords = "attitudes, factor analysis, genetic testing, genomics, optimism, pessimism, statistical",
author = "Caroline Horrow and Pacyna, {Joel E.} and Sutton, {Erica J.} and Sperry, {Beau P.} and {Radecki Breitkopf}, Carmen and Sharp, {Richard R}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/cge.13535",
language = "English (US)",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Assessing optimism and pessimism about genomic medicine

T2 - Development of a genomic orientation scale

AU - Horrow, Caroline

AU - Pacyna, Joel E.

AU - Sutton, Erica J.

AU - Sperry, Beau P.

AU - Radecki Breitkopf, Carmen

AU - Sharp, Richard R

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Efforts to characterize stakeholder attitudes about the implementation of genomic medicine would benefit from a validated instrument for measuring public views of the potential benefits and harms of genomic technologies, which would facilitate comparison across populations and clinical settings. We sought to develop a scale to evaluate attitudes about the future of genomic medicine. We developed a 21-item scale that examined the likelihood of various outcomes of genomic medicine. The scale was administered to participants in a genomic sequencing study. Exploratory factor analysis was conducted and bivariate correlations were calculated. The genomic orientation (GO) scale was completed by 2895 participants. A two-factor structure was identified, corresponding to an optimism subscale (16 items, α = 0.89) and a pessimism subscale (5 items, α = 0.63). Genomic optimism was positively associated with a perceived value of genetic test results, higher health literacy, and decreased decisional conflict about participation in a genomic research study. Genomic pessimism was associated with concerns about genetic testing, lower health literacy, and increased decisional conflict about the decision to participate in the study. The GO scale is a promising tool for measuring both positive and negative views regarding the future of genomic medicine and deserves further validation.

AB - Efforts to characterize stakeholder attitudes about the implementation of genomic medicine would benefit from a validated instrument for measuring public views of the potential benefits and harms of genomic technologies, which would facilitate comparison across populations and clinical settings. We sought to develop a scale to evaluate attitudes about the future of genomic medicine. We developed a 21-item scale that examined the likelihood of various outcomes of genomic medicine. The scale was administered to participants in a genomic sequencing study. Exploratory factor analysis was conducted and bivariate correlations were calculated. The genomic orientation (GO) scale was completed by 2895 participants. A two-factor structure was identified, corresponding to an optimism subscale (16 items, α = 0.89) and a pessimism subscale (5 items, α = 0.63). Genomic optimism was positively associated with a perceived value of genetic test results, higher health literacy, and decreased decisional conflict about participation in a genomic research study. Genomic pessimism was associated with concerns about genetic testing, lower health literacy, and increased decisional conflict about the decision to participate in the study. The GO scale is a promising tool for measuring both positive and negative views regarding the future of genomic medicine and deserves further validation.

KW - attitudes

KW - factor analysis

KW - genetic testing

KW - genomics

KW - optimism

KW - pessimism

KW - statistical

UR - http://www.scopus.com/inward/record.url?scp=85063779021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063779021&partnerID=8YFLogxK

U2 - 10.1111/cge.13535

DO - 10.1111/cge.13535

M3 - Article

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

ER -